loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for MolPort-001-759-947

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    MolPort-001-759-947

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 24Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Graviti Pharmaceuticals' Generic Chlorzoxazone Receives Approval in the U.S.
    Graviti Pharmaceuticals' Generic Chlorzoxazone Receives Approval in the U.S.

    09 Aug 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216925

    FDA
    09 Aug 2023
    Share Share
    CorePharma's Generic Chlorzoxazone Receives Approval in the U.S.
    CorePharma's Generic Chlorzoxazone Receives Approval in the U.S.

    20 Oct 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214941

    FDA
    20 Oct 2022
    Share Share
    Enforcement Report - Week of September 29, 2021
    Enforcement Report - Week of September 29, 2021

    29 Sep 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-29-2021-1632907538.pdf

    FDA
    29 Sep 2021
    Share Share
    Havix's Generic Chlorzoxazone Receives Tentative Approval In US
    Havix's Generic Chlorzoxazone Receives Tentative Approval In US

    29 Jul 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215158

    FDA
    29 Jul 2021
    Share Share
    Par Pharm`s Generic Chlorzoxazone Receives Approval in US
    Par Pharm`s Generic Chlorzoxazone Receives Approval in US

    04 Nov 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212743

    FDA
    04 Nov 2020
    Share Share
    I3 Pharms's Generic Chlorzoxazone Receives Approval In US
    I3 Pharms's Generic Chlorzoxazone Receives Approval In US

    15 Sep 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212053

    FDA
    15 Sep 2020
    Share Share